Edition:
United States

Insider Trading: Endo International PLC (ENDP.O)

ENDP.O on Nasdaq

23.39USD
23 Sep 2016
Change (% chg)

$3.13 (+15.45%)
Prev Close
$20.26
Open
$20.91
Day's High
$23.98
Day's Low
$20.90
Volume
21,089,683
Avg. Vol
7,760,284
52-wk High
$77.21
52-wk Low
$12.56

RUDIO DANIEL A
Trading Date Type Shares Traded Price Shares Held
26 Feb 2016 Sell 287 $53.80 4,408
25 Feb 2016 Sell 86 $53.80 4,408
23 Feb 2016 Sell 79 $49.85 3,898
22 Feb 2016 Buy 1,306 $0.00 3,898
21 Feb 2016 Sell 192 $50.70 3,793
26 Feb 2015 Sell 251 $85.34 3,285
25 Feb 2015 Sell 81 $85.19 3,285
23 Feb 2015 Buy 735 $0.00 1,537
22 Feb 2015 Sell 138 $85.82 2,734
21 Feb 2015 Sell 192 $85.30 2,734

Institutional Holders

% Shares Owned: 98.87%
# of Holders: 473
Total Shares Held: 220,241,122
3 Mo. Net Change: -1,102,255
# New Positions: 62
# Closed Positions: 116
# Increased Positions: 233
# Reduced Positions: 246
# Net Buyers: -13

Officers & Directors

Name Age Since Current Position

Roger Kimmel

69 2007 Independent Chairman of the Board

Rajiv De Silva

49 President, Chief Executive Officer, Director

Suketu Upadhyay

45 2013 Chief Financial Officer, Executive Vice President

Camille Farhat

45 2012 President of American Medical Systems

Brian Lortie

54 President, U.S. Branded Pharmaceuticals

Susan Hall

56 2014 Executive Vice President, Chief Scientific Officer, and Global Head of Research & Development and Quality

Matthew Maletta

44 2015 Executive Vice President, Chief Legal Officer

Donald Degolyer

Chief Operating Officer, Pharmaceuticals

Craig Paterson

2015 Chief Medical Officer

Douglas Ingram

53 2016 Director

Todd Sisitsky

44 2016 Director

Shane Cooke

52 2014 Independent Director

Arthur Higgins

59 2013 Independent Director

Nancy Hutson

65 2009 Independent Director

Michael Hyatt

69 Independent Director

William Montague

68 2009 Independent Director

Jill Smith

58 2012 Independent Director

William Spengler

60 2008 Independent Director